Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women

Journal of the International AIDS Society

Volumn 16, Issue , 2013, Pages

  Myer, Landon ^a   Daskilewicz, Kristen ^a   McIntyre, James ^a,b   Bekker, Linda Gail ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ANOVA HEALTH INSTITUTE   (South Africa)

Author keywords

Antiretroviral therapy; CD4 cell count; HIV; Point of care test; Pregnancy; Reliability; South Africa

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PREGNANCY DISORDER; PREGNANT WOMAN; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SOUTH AFRICA; THIRD TRIMESTER PREGNANCY; YOUNG ADULT; ANTIRETROVIRAL THERAPY; DIAGNOSTIC PROCEDURE; EVALUATION STUDY; HOSPITAL INFORMATION SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; METHODOLOGY; POINT-OF-CARE TEST; PREGNANCY; RELIABILITY; PROCEDURES;

ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; HIV; POINT-OF-CARE TEST; PREGNANCY; RELIABILITY; SOUTH AFRICA;

ADULT; CD4 LYMPHOCYTE COUNT; CLINICAL LABORATORY TECHNIQUES; FEMALE; HIV INFECTIONS; HUMANS; POINT-OF-CARE SYSTEMS; PREGNANCY; PREGNANT WOMEN; SOUTH AFRICA; YOUNG ADULT;

EID: 84891656833     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.16.1.18649     Document Type: Article

References (24)

1. Mofenson LM. Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection. Clin Infect Dis. 2010; 50(Suppl 3):S130-48.
2. Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health. 2010;15(7):825-32.
3. Weigel R, Hosseinipour MC, Feldacker C, Gareta D, Tweya H, Chiwoko J, et al. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi. Trop Med Int Health. 2012; 17(6):751-9.
4. Ferguson L, Lewis J, Grant AD, Watson-Jones D, Vusha S, Ong'ech JO, et al. Patient attrition between diagnosis with HIV in pregnancy-related services and long-term HIV care and treatment services in Kenya: a retrospective study. J Acquir Immune Defic Syndr. 2012;60(3):e90-7.
5. World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. Geneva: WHO; 2011.
6. Myer L. Initiating antiretroviral therapy in pregnancy: the importance of timing. J Acquir Immune Defic Syndr. 2011;58(2):125-6.
7. Zachariah R, Reid SD, Chaillet P, Massaquoi M, Schouten EJ, Harries AD. Viewpoint: why do we need a point-of-care CD4 test for low-income countries? Trop Med Int Health. 2011;16(1):37-41.
8. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011;378(9802):1572-9.
9. Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr. 2012;61(2):e13-7.
10. Myer L, Zulliger R, Black S, Pienaar D, Bekker LG. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa. AIDS Care. 2012;24(8):986-92.
11. Glencross DK, Coetzee LM, Faal M, Masango M, Stevens WS, Venter WF, et al. Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc. 2012;15(1):3.
12. Faal M, Naidoo N, Glencross DK, Venter WD, Osih R. Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr. 2011;58(3):e54-9.
13. Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, Pattanapanyasat K. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. J Acquir Immune Defic Syndr. 2011;58(2):141-7.
14. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, Mugurungi O, Gudukeya S, Hatzold K, et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr. 2010;55(1):1-7.
15. Mnyani CN, McIntyre JA, Myer L. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy. J Acquir Immune Defic Syndr. 2012;60(3):260-4.
16. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Aggett HM, Scott LE, et al. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Cytometry B Clin Cytom. 2008;74(Suppl 1):S40-51.
17. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;32:307-17.
18. Van Schaik N, Kranzer K, Myer L, Raditlhalo E, Thebus E, Davies N, et al. Field validation of the PIMA analyzer in a mobile clinic setting in South Africa. Poster #673 presented at the 18th Conference on Retroviruses and Opportunistic Infections; 2011 Feb 27-Mar 2; Boston, MA.
19. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related millennium development goals: time for a public health approach. Lancet. 2011;378(9787):282-4.
20. Ekouevi DK, Inwoley A, Tonwe-Gold B, Danel C, Becquet R, Viho I, et al. Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings. AIDS Res Hum Retroviruses. 2007;23(12):1469-74.
21. Gelson E, Ogueh O, Johnson M. Cardiovascular Changes in Normal Pregnancy. London: RCOG Press; 2006.
22. Blackburn ST, Loper DL. Maternal, fetal, and neonatal physiology: a clinical perspective. Philadelphia: WB Saunders; 1992.
23. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. June 2013. Geneva: WHO; 2013.
24. Larson B, Schnippel K, Ndibongo B, Long L, Fox MP, Rosen S. How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa. PLoS One. 2012;7(4):e35444.